Evidence map›Paper›PMID 37243154›Full record

ArticleViruses2023

Repurposing of Doramectin as a New Anti-Zika Virus Agent.

Yujia Zhu, Minqi Liang, Jianchen Yu, Bingzhi Zhang, Ge Zhu, Yun Huang, Zhenjian He, Jie Yuan

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Antiviral Activity ofInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yujia ZhuSchool of Public Health, Sun Yat-sen University, Guangzhou 510080, China.ORCID 0000-0002-6618-9294
Minqi LiangSchool of Public Health, Sun Yat-sen University, Guangzhou 510080, China.
Jianchen YuSchool of Chemistry, South China Normal University, Guangzhou 510006, China.
Bingzhi ZhangSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Ge ZhuZhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
Yun HuangSchool of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
Zhenjian HeSchool of Public Health, Sun Yat-sen University, Guangzhou 510080, China.
Jie YuanKey Laboratory of Tropical Disease Control (Sun Yat-sen University), Ministry of Education, Guangzhou 510080, China.
Sun Yat-sen University · CNGuangdong Pharmaceutical University · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zika virus (ZIKV), belonging to the

Indexed as

Zika VirusZika Virus InfectionAnimalsAntiviral AgentsDrug RepositioningIvermectinVirus ReplicationAntiviral AgentsdoramectinIvermectinantiviral agentdoramectinRdRpZIKV

Identifiers

PMID37243154
PMCPMC10221537
OpenAlexW4367181875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.